文献速递眼底病与葡萄膜炎

非甾体抗炎药使用与年龄相关性黄斑变性的关系

The Relationship Between Nonsteroidal Anti-inflammatory Drug Use and Age-related Macular Degeneration.
PubMed 文献 · Am J Ophthalmol · 2018-01-31

研究纳入加利福尼亚男性健康研究51 371名男性,随访平均7.4年,评估非甾体抗炎药(NSAIDs)使用与年龄相关性黄斑变性(AMD)发病的关系。长期使用任何NSAIDs与渗出性AMD风险降低相关(HR 0.69,95%CI 0.50-0.96,P=.029);新使用任何NSAIDs和 aspirin 与 nonexudative AMD 风险降低相关,但长期使用未见持续趋势。总体影响较小,长期使用NSAIDs者渗出性AMD风险降低可能提示保护作用,需进一步研究。

要点

  • 长期使用任何NSAIDs与渗出性AMD风险降低相关(HR 0.69,95%CI 0.50-0.96,P=.029)。
  • 新使用任何NSAIDs(HR 0.79,95%CI 0.68-0.93,P=.0039)和新使用aspirin(HR 0.82,95%CI 0.70-0.97,P=.018)与 nonexudative AMD 风险降低相关,长期使用未见持续趋势。
  • 其他NSAID使用类别与渗出性或 nonexudative AMD 的关系无显著差异。

核心结论

  • NSAIDs对AMD发病的总体影响较小;长期使用NSAIDs者渗出性AMD风险降低可能提示保护作用,需进一步研究作为调节疾病风险的潜在机制。

研究设计与样本

  • 前瞻性队列研究,纳入加利福尼亚男性健康研究中完成2002-2003年和2006年调查的男性,共51 371人,平均随访7.4年。

主要发现

  • 共发生292例(0.6%)渗出性AMD和1536例(3%) nonexudative AMD。
  • 长期使用任何NSAIDs与渗出性AMD风险降低相关(HR 0.69,95%CI 0.50-0.96,P=.029)。
  • 新使用任何NSAIDs与 nonexudative AMD 风险降低相关(HR 0.79,95%CI 0.68-0.93,P=.0039)。
  • 新使用aspirin与 nonexudative AMD 风险降低相关(HR 0.82,95%CI 0.70-0.97,P=.018),但该趋势在长期使用者中未持续。
  • 其他NSAID使用类别与渗出性或 nonexudative AMD 的关系无显著差异。

关键数值与推荐

  • NSAID使用者定义为2002-2003年和2006年调查中自报每周至少3天使用aspirin、ibuprofen、naproxen、valdecoxib、celecoxib和/或rofecoxib者。
  • 根据调查回答将患者分为非使用者、既往使用者、新使用者和长期使用者;NSAID使用也按类型分类:任何NSAIDs、aspirin和/或非aspirin NSAIDs。
  • 多变量分析纳入年龄、种族/民族、吸烟状况、教育、收入、酒精使用和Charlson合并症指数评分作为AMD风险因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe the relationship between the incidence of age-related macular degeneration (AMD) and nonsteroidal anti-inflammatory drug (NSAIDs) use. DESIGN: Prospective cohort study. METHODS: This study consisted of participants in the California Men's Health Study. Those who completed surveys in 2002-2003 and 2006 were included. Men who self-reported use of aspirin, ibuprofen, naproxen, valdecoxib, celecoxib, and/or rofecoxib at least 3 days per week were considered NSAID users. Patients were categorized as non-users, former users, new users, or longer-term users based on survey responses. NSAID use was also categorized by type: any NSAIDs, aspirin, and/or non-aspirin NSAIDs. Age, race/ethnicity, smoking status, education, income, alcohol use, and Charlson comorbidity index score were included in the multivariate analysis as risk factors for AMD. RESULTS: A total of 51 371 men were included. Average follow-up time was 7.4 years. There were 292 (0.6%) and 1536 (3%) cases of exudative and nonexudative AMD, respectively. Longer-term use of any NSAID was associated with lower risk of exudative AMD (hazard ratio [HR] 0.69, 95% confidence interval [CI] 0.50-0.96, P = .029). New users of any NSAIDs (HR = 0.79, 95% CI 0.68-0.93, P = .0039) and aspirin (HR = 0.82, 95% CI 0.70-0.97, P = .018) had a lower risk of nonexudative AMD, although this trend did not persist in longer-term users. The relationship between exudative or nonexudative AMD and the remaining categories of NSAID use were not significant. CONCLUSION: The overall impact of NSAIDs on AMD incidence is small; however, the lower risk of exudative AMD in longer-term NSAID users may point to a protective effect and deserves further study as a possible mechanism to modulate disease risk.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Modjtahedi BS, Fong DS, Jorgenson E, et al. The Relationship Between Nonsteroidal Anti-inflammatory Drug Use and Age-related Macular Degeneration. Am J Ophthalmol. 2018. PMID: 29360460. doi:10.1016/j.ajo.2018.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。